What changed in muscle and ligaments
TB-500 and muscle recovery: what changed
Repair cells moved after thymosin beta-4. Strength didn't improve in one key mouse test. Both results matter.
What linked TB-500 to muscle repair
Muscle researchers first watched thymosin beta-4 after damage. They wanted to see which cells came to help. The full protein drew repair cells toward hurt tissue. A 2021 study also found it in human blood after exercise [15]. That made TB-500 seem worth studying. Yet the best findings still came from animals given the full protein [1].
The full protein's lab weight is about 4963 daltons. A dalton is an atom-sized weight unit. The figure helps show that the full protein is much larger. Muscle, ligament, and wound tests used full thymosin beta-4. They didn't use TB-500 unless the study says so. People still lack a finished, fair recovery test of TB-500 [4]. Keep that limit beside each claim.
What grew in muscle while strength stayed low
Hurt muscle made more thymosin beta-4. Repair cells then moved into the damaged area [6]. Those cells help rebuild muscle. Their movement was a useful first step. It didn't prove that the muscle became stronger.
Another team used mice bred to have very weak muscles. The mice got 150 micrograms of thymosin beta-4 by belly shot. For six months, shots came on two days each week. The mice formed a larger number of fresh muscle fibers. Yet strength didn't improve. The heart didn't pump better. Heart and muscle still had heavy scar tissue [8].
More fibers. No gain in strength.
A microscope can show extra tissue. Your leg may still work no better. The mouse test found both results.
What healed in a rat's knee ligament
One team injured a knee ligament in rats. A ligament is the strong band connecting one bone to another. Full thymosin beta-4 helped the ligament heal [7]. That test is closer to a sports injury than a heart test.
The rats still didn't get the small copy. No direct human study tested TB-500 for tendon or ligament harm [4]. Rat wounds grew skin faster and made more collagen. Collagen is a protein that gives tissue strength [2]. Those facts fit repair. They don't prove your tendon will heal faster.
How access is structured
The prescription channel, and what it does not settle
Nearly everything sold to the recovery audience as TB-500 is research-chemical stock: laboratory-use labelling, no prescriber anywhere in the chain, and nobody accountable for what is actually in the vial. The other channel is the prescription one — Promise Peptides (mypromise.com) lists TB-500 among its clinician-prescribed, prescription-only peptides, where a licensed clinician evaluates the patient and sets the protocol instead of the buyer doing both jobs at once. Noting that the channel exists settles none of the argument above. The fragment still has no completed controlled human trial, the null result on muscle strength still stands, and the tumour and angiogenesis signal remains the open safety question; FDA's page, content current as of April 22, 2026, says the nomination was withdrawn and no longer lists TB-500 in Category 2, as the legal status page explains. A prescription changes who is accountable for the decision; it does not change the evidence.
What separates TB-500 from BPC-157
TB-500 and BPC-157 are often named together. Both are lab-made peptides, or short protein chains. They aren't two forms of one substance. TB-500 copies part of thymosin beta-4. It holds actin and may affect how cells move [1]. BPC-157 is a different lab-made chain with different studies.
The TB-500 facts are fairly short. Scientists saw the copied part hold actin [1]. Rat wounds closed faster with thymosin beta-4 [2]. A rat ligament healed better [7]. Muscle repair cells moved toward damage [6]. No finished human trial tested TB-500 [4]. New vessels also raise the main cancer worry [12].
A 2026 Sports Medicine review compared the small copy, the full protein, and BPC-157 [14]. Animal tests often found better tissue repair. Human safety proof was scarce. Serious harm was still possible. The products also sat outside normal drug checks. Read the TB-500 legal status and pharmacy access before judging a claim.
What TB-500 muscle claims leave out
After muscle damage, repair cells moved into hurt tissue under thymosin beta-4. Both animal work and dish work showed the move [6]. A later study found thymosin beta-4 in human blood after exercise [15]. Both findings involved the full protein. No fair human recovery trial tested TB-500. Mice grew more fibers, but their strength didn't rise [8].
What TB-500 tendon proof is still missing
Rat knee ligaments healed better after full thymosin beta-4 [7]. Few tests looked this closely at a ligament. People weren't tested. The small copy wasn't tested. No direct human tendon or ligament result exists for TB-500 [4]. Rat wound work also points toward repair [2]. Your own tendon may act quite differently.
What TB-500 and BPC-157 each come from
Both are lab-made peptides, meaning short protein chains. They were studied for tissue repair. They aren't the same substance. TB-500 copies an actin-holding part of thymosin beta-4. BPC-157 is a different peptide [1]. Its shape and studies differ. The pages here cover TB-500 only.
What a review found about TB-500 recovery claims
A 2026 Sports Medicine review checked TB-500 and other unapproved peptides [14]. Animal tests often found better tissue repair. Human safety facts were scarce. The reviewers also saw a chance of serious harm. Most products lacked the usual drug checks. Animal results may guide more study. They don't settle what happens to you.
What TB-500 healing-speed claims leave out
No sound human time line exists for the small copy [4]. One test gave rats deep skin wounds. Full thymosin beta-4 helped new skin grow. Growth rose 42% at four days. It reached 61% at seven days versus salt water [2]. That is a rat result, not your schedule. Online time claims haven't faced a fair trial.